[Brief Introduction of Seminar]
As the market shifts toward regenerative aesthetics, reconstructing the Extracellular Matrix (ECM) is the ultimate key. We will introduce new cutting-edge biomaterials,including dECM, PDRN/PN, recombinant collagen, chondroitin sulfate and carboxymethyl chitosan — that synergistically restore the cellular microenvironment. Backed by scientific evidence, these high-purity ingredients empower medical device manufacturers to formulate next-generation, high-performance injectables. Explore the B2B solutions that will redefine the future of youth.
[Brief Introduction of Speaker]
Bloomage Biotechnology, Pharmaceutical Materials BG-Aesthetic Materials Division
Sales Director
- KS Bio, Overseas Business Department Team Leader
- Guangzhou Sumira Academy Advisor
- Advisor at Shanghai Suenmi Plastic Surgery Hospital
- Haesung Korea Biotech, Sales Team Leader